Clinical Trials Logo
  1. Home
  2. MPS IVA
  3. NCT01961518

Screening an Orthopedic Population for Mildly-affected Individuals With Morquio Syndrome A and Maroteaux-Lamy Syndrome

MPS IVA Clinical Trial

Official title:
Screening an Orthopedic Population for Mildly-affected Individuals With Morquio Syndrome Type A and Maroteaux-Lamy Syndrome

Clinical Trial Summary

The purpose of this study is to identify patients with Morquio syndrome type A (MPS IVA) and Maroteaux-Lamy syndrome (MPS VI) who may have been missed or misdiagnosed due to atypical clinical features, a milder course, and/or negative urine screening. We will recruit participants who have certain hip and/or joint problems that could potentially be caused by one of these two genetic conditions through a chart review process conducted at Shriners Hospital for Children in Greenville, SC. Diagnostic testing will be performed for each participant to determine if he or she is affected by one of these two conditions. Results will be disclosed to all participants and their legal guardians, and appropriate follow up will be recommended for those who are found to have abnormal results.

Clinical Trial Description

n/a

Study Design

Observational Model: Case-Only, Time Perspective: Retrospective

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01961518
Study type Observational
Source Greenwood Genetic Center
Contact
Status Completed
Phase N/A
Start date October 2013
Completion date May 2015
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05845749 - Safety and Efficacy of Voxzogo for Growth Deficits in MPS IVA and VI Phase 1/Phase 2
Completed NCT02294877 - A Multicenter, Multinational, Observational Morquio A Registry Study (MARS)
Completed NCT01515956 - Study of BMN 110 in Pediatric Patients < 5 Years of Age With Mucopolysaccharidosis IVA (Morquio A Syndrome) Phase 2
Recruiting NCT05284006 - Non-invasive Functional Assessment and Pathogenesis of Morquio A
Completed NCT01415427 - Long-Term Efficacy and Safety Extension Study of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome) Phase 3
Recruiting NCT04532047 - In Utero Enzyme Replacement Therapy for Lysosomal Storage Diseases Phase 1
Completed NCT01920828 - Gait Analysis in MPS IVA
Terminated NCT01697319 - Efficacy and Safety Study of BMN 110 for Morquio A Syndrome Patients Who Have Limited Ambulation Phase 2
Terminated NCT01609062 - Safety and Exercise Study of Two Doses of BMN 110 for Morquio A Syndrome Phase 2
Approved for marketing NCT01858103 - BMN 110 US Expanded Access Program N/A